|
1.
|
Yasui W, Sentani K, Sakamoto N, Anami K,
Naito Y and Oue N: Molecular pathology of gastric cancer: research
and practice. Pathol Res Pract. 207:608–612. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Brenner B, Hoshen MB, Purim O, David MB,
Ashkenazi K, Marshak G, Kundel Y, Brenner R, Morgenstern S, Halpern
M, Rosenfeld N, Chajut A, Niv Y and Kushnir M: MicroRNAs as a
potential prognostic factor in gastric cancer. World J
Gastroenterol. 17:3976–3985. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Marx J: Cancer research: mutant stem cells
may seed cancer. Science. 301:1308–1310. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Singh SK, Hawkins C, Clarke ID, Squire JA,
Bayani J, Hide T, Henkelman RM, Cusimano MD and Dirks PB:
Identification of human brain tumour initiating cells. Nature.
432:396–401. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Clarke MF, Dick JE, Dirks PB, Eaves CJ,
Jamieson CH, Jones DL, Visvader J, Weissman IL and Wahl GM: Cancer
stem cells: perspectives on current status and future directions -
AACR Workshop on Cancer Stem Cells. Cancer Res. 66:9339–9344. 2006.
View Article : Google Scholar
|
|
6.
|
Takaishi S, Okumura T, Tu S, Wang SS,
Shibata W, Vigneshwaran R, Gordon SA, Shimada Y and Wang TC:
Identification of gastric cancer stem cells using the cell surface
marker CD44. Stem Cells. 27:1006–1020. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Han ME, Jeon TY, Hwang SH, Lee YS, Kim HJ,
Shim HE, Yoon S, Baek SY, Kim BS, Kang CD and Oh SO: Cancer spheres
from gastric cancer patients provide an ideal model system for
cancer stem cell research. Cell Mol Life Sci. 68:3589–3596. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Singh SK, Clarke ID, Terasaki M, Bonn VE,
Hawkins C, Squire J and Dirks PB: Identification of a cancer stem
cell in human brain tumors. Cancer Res. 63:5821–5828.
2003.PubMed/NCBI
|
|
9.
|
Ponti D, Costa A, Zaffaroni N, Pratesi G,
Petrangolini G, Coradini D, Pilotti S, Pierotti MA and Daidone M:
Isolation and in vitro propagation of tumorigenic breast cancer
cells with stem/progenitor cell properties. Cancer Res.
65:5506–5511. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Fujii H, Honoki K, Tsujiuchi T, Kido A,
Yoshitani K and Takakura Y: Sphere-forming stem-like cell
populations with drug resistance in human sarcoma cell lines. Int J
Oncol. 34:1381–1386. 2009.PubMed/NCBI
|
|
11.
|
Jordan CT, Guzman ML and Noble M: Cancer
stem cells. N Engl J Med. 355:1253–1261. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Dalerba P, Cho RW and Clarke MF: Cancer
stem cells: models and concepts. Annu Rev Med. 58:267–284. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Ricci-Vitiani L, Lombardi DG, Pilozzi E,
Biffoni M, Todaro M, Peschle C and De Maria R: Identification and
expansion of human colon-cancer-initiating cells. Nature.
445:111–115. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Dean M, Fojo T and Bates S: Tumor stem
cells and drug resistance. Nat Rev Cancer. 5:275–284. 2005.
View Article : Google Scholar
|
|
16.
|
Chiba T, Kita K, Zheng YW, Yokosuka O,
Saisho H, Iwama A, Nakauchi H and Taniguchi H: Side population
purified from hepatocellular carcinoma cells harbors cancer stem
cell-like properties. Hepatology. 44:240–251. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Szotek PP, Pieretti-Vanmarcke R, Masiakos
PT, Dinulescu DM, Connolly D, Foster R, Dombkowski D, Preffer F,
Maclaughlin DT and Donahoe PK: Ovarian cancer side population
defines cells with stem cell-like characteristics and Mullerian
inhibiting substance responsiveness. Proc Natl Acad Sci USA.
103:11154–11159. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Lee J, Kotliarova S, Kotliarov Y, Li A, Su
Q, Donin NM, Pastorino S, Purow BW, Christopher N, Zhang W, Park JK
and Fine HA: Tumor stem cells derived from glioblastomas cultured
in bFGF and EGF more closely mirror the phenotype and genotype of
primary tumors than do serum-cultured cell lines. Cancer Cell.
9:391–403. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Bao S, Wu Q, McLendon RE, Hao Y, Shi Q,
Hjelmeland AB, Dewhirst MW, Bigner DD and Rich JN: Glioma stem
cells promote radio-resistance by preferential activation of the
DNA damage response. Nature. 444:756–760. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Rocco A, Liguori E, Pirozzi G, Tirino V,
Compare D, Franco R, Tatangelo F, Palaia R, D’Armiento FP,
Pollastrone G, Affuso A, Bottazzi EC, Masone S, Persico G and
Nardone G: CD133 and CD44 cell surface markers do not identify
cancer stem cells in primary human gastric tumors. J Cell Physiol.
227:2686–2693. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Fukuda K, Saikawa Y, Ohashi M, Kumagai K,
Kitajima M, Okano H, Matsuzaki Y and Kitagawa Y: Tumor initiating
potential of side population cells in human gastric cancer. Int J
Oncol. 34:1201–1207. 2009.PubMed/NCBI
|
|
22.
|
Patrawala L, Calhoun T,
Schneider-Broussard R, Zhou J, Claypool K and Tang DG: Side
population is enriched in tumorigenic, stem-like cancer cells,
whereas ABCG2+ and ABCG2− cancer cells are
similarly tumorigenic. Cancer Res. 65:6207–6219. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Burkert J, Otto WR and Wright NA: Side
populations of gastrointestinal cancers are not enriched in stem
cells. J Pathol. 214:564–573. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Zhang S, Balch C, Chan MW, Lai HC, Matei
D, Schilder JM, Yan PS, Huang TH and Nephew KP: Identification and
characterization of ovarian cancer-initiating cells from primary
human tumors. Cancer Res. 68:4311–4320. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Fujii H, Honoki K, Tsujiuchi T, Kido A,
Yoshitani K and Takakura Y: Sphere-forming stem-like cell
populations with drug resistance in human sarcoma cell lines. Int J
Oncol. 34:1381–1386. 2009.PubMed/NCBI
|
|
26.
|
Rappa G, Mercapide J, Anzanello F,
Prasmickaite L, Xi Y, Ju J, Fodstad O and Lorico A: Growth of
cancer cell lines under stem cell-like conditions has the potential
to unveil therapeutic targets. Exp Cell Res. 314:2110–2122. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Ponti D, Costa A, Zaffaroni N, Pratesi G,
Petrangolini G, Coradini D, Pilotti S, Pierotti MA and Daidone M:
Isolation and in vitro propagation of tumorigenic breast cancer
cells with stem/progenitor cell properties. Cancer Res.
65:5506–5511. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Boyer LA, Lee TI, Cole MF, Johnstone SE,
Levine SS, Zucker JP, Guenther MG, Kumar RM, Murray HL, Jenner RG,
Gifford DK, Melton DA, Jaenisch R and Young RA: Core
transcriptional regulatory circuitry in human embryonic stem cells.
Cell. 122:947–956. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Kashyap V, Rezende NC, Scotland KB,
Shaffer SM, Persson JL, Gudas LJ and Mongan NP: Regulation of stem
cell pluripotency and differentiation involves a mutual regulatory
circuit of the NANOG, OCT4, and SOX2 pluripotency transcription
factors with polycomb repressive complexes and stem cell microRNAs.
Stem Cells Dev. 18:1093–1108. 2009. View Article : Google Scholar
|
|
30.
|
Collins AT, Berry PA, Hyde C, Stower MJ
and Maitland NJ: Prospective identification of tumorigenic prostate
cancer stem cells. Cancer Res. 65:10946–10951. 2005. View Article : Google Scholar : PubMed/NCBI
|
